| Data | Hora | Fonte | Título | Código | Companhia |
| 13/09/2017 | 10:40 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 13/09/2017 | 10:34 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 07/09/2017 | 09:51 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 09/08/2017 | 09:48 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 29/06/2017 | 18:00 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 29/06/2017 | 17:52 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 09/06/2017 | 11:39 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 06/06/2017 | 07:04 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 11/05/2017 | 17:31 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 27/04/2017 | 17:40 | Edgar (US Regulatory) | (25) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 27/04/2017 | 17:35 | Edgar (US Regulatory) | Securities Registration (section 12(b)) (8-a12b) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 27/04/2017 | 17:15 | PR Newswire (US) | Savara Announces Closing Of Merger With Mast Therapeutics | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 25/04/2017 | 09:01 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 25/04/2017 | 09:00 | PR Newswire (US) | Mast Therapeutics And Savara Announce Anticipated Merger Exchange Ratio | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 21/04/2017 | 14:00 | PR Newswire (US) | Mast Therapeutics Announces Adjournment Of Special Stockholders Meeting | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 20/04/2017 | 09:00 | PR Newswire (US) | Mast Therapeutics Announces Possible Adjournment Of Special Stockholders Meeting To Solicit Additional Votes For Merger With ... | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 17/04/2017 | 09:00 | PR Newswire (US) | Mast Reminds Stockholders To Vote For The Proposed Merger With Savara | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 11/04/2017 | 09:00 | PR Newswire (US) | Leading Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Mast Therapeutics Stockholders Vote "FOR" The Proposed... | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 10/04/2017 | 09:00 | PR Newswire (US) | Mast Therapeutics And Savara Announce Approval To List Common Stock On The Nasdaq Capital Market | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 16/03/2017 | 09:00 | PR Newswire (US) | Mast Therapeutics Sets Date For Special Meeting Of Stockholders To Vote On Proposed Merger With Savara | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 16/03/2017 | 07:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 15/03/2017 | 17:37 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 13/03/2017 | 17:09 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 13/03/2017 | 07:03 | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 06/03/2017 | 18:50 | Edgar (US Regulatory) | Annual Report (10-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 06/03/2017 | 18:30 | PR Newswire (US) | Mast Therapeutics Reports Fourth Quarter And Full Year 2016 Financial Results | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 06/03/2017 | 10:00 | PR Newswire (US) | Mast Therapeutics Announces Clinical Study Of AIR001 For The Treatment Of Chronic Infection In Cystic Fibrosis Patients | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 10/02/2017 | 20:16 | Edgar (US Regulatory) | Securities Registration: Business Combination (s-4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 09/01/2017 | 19:25 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 07/01/2017 | 16:00 | PR Newswire (US) | Mast Therapeutics And Savara Sign Merger Agreement | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |